Registration Now Open for AI Summit 2023

YORK, Penn. – The AFDO/RAPS Healthcare Products Collaborative announced that registration is now open for the AI Global Healthcare Initiative’s AI Summit 2023, taking place Nov. 14-16 at the Westin Cincinnati.

This annual summit brings together regulatory authorities, healthcare leaders and AI experts across industry, government, and academia to collaborate for our patients and elevate the industry as a whole. Through interactive sessions, hands-on workshops and purpose-driven discussions, attendees will tackle hurdles to AI adoption and implement solutions that advance patient care.

“We’re looking forward to uniting the best minds in Cincinnati to shape the future of healthcare with AI,” said Timothy Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative. “The AI Summit facilitates the level of cooperation and dialogue needed to develop practical frameworks that responsibly harness the power of AI to improve lives.”

A Strategic Committee of industry experts guides the AI Summit program development. The Strategic Committee includes: 

• Pat Baird, Regulatory Head of Global Software Standards, Philips;
• Matthew Diamond, CMO for Digital Health, FDA-CDRH Digital Health Center of Excellence;
• Brian Edwards, Fellow, Regulatory Affairs, Digital Health/Cybersecurity, Boston Scientific;
• Steve Frigon, Data Integration Team Lead, The Christ Hospital Health Network;
• Lacey Harbour, Regulatory Affairs Manager, Thermo Fisher Scientific;
• Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding;
• Timothy Hsu, Chief Collaboration Officer, AFDO/RAPS Healthcare Products Collaborative;
• Cynthia A. Ipach, President and CEO, Compliance Insight;
• Cindi Linville, Director of Quality/Regulatory Affairs, Best Sanitizers;
• Toni Manzano, Co-founder and CSO, Aizon;
• Rohit Nayak, CEO, Electronic Registry Systems, Inc.;
• Bakul Patel, Senior Director, Global Digital Health Strategy & Regulatory, Google;
• Dharmesh Patel, Associate Director Regulatory Policy, BD;
• Cassie Scherer, Senior Director, U.S. Regulatory and Global Digital Health Policy, Medtronic;
• Matthew Schmucki, Associate Director of Automation Engineering, Vertex Pharmaceuticals;
• Bradley Thompson, Attorney and Chief Data Scientist focused on FDA, FTC & AI Regulation, Epstein Becker & Green;
• Mohammed Wahab, Quality Head, Professional Services – Informatics & Analytics, Abbott Laboratories;
• Kip Wolf, Head of Technical Operations and Portfolio Management, X-VAX Technology, Inc.

The AI Summit agenda features interactive sessions that create a behind-the-scenes experience into how AI is being used in pharma, biopharma and medical devices. Topics covered will include emerging AI applications, understanding and managing bias in AI, cybersecurity, and the AI software development lifecycle. In addition, attendees will hear about updates on the global AI/ML regulations and standards, the FDA’s PCCP draft guidance and insights from the FDA Digital Health Center of Excellence.

To learn more and register, visit the AI Summit website.